Aspira Pathlab & Diagnostics Ltd

BSE :540788 NSE :- Sector : Healthc..
63.34
Change: 1.24(2.00%)
Created with Highstock 5.0.71D1W1M3M1Y5YMax10:3011:1511:3511:5012:2013:1514:0014:3014:5015:1015:3016:0011:4512:1512:4013:3014:1514:4510:3011:3511:5513:1514:3015:1016:0062.0063.0064.00
52 week Low
25.00
52 week High
83.93
Day low
62.10
Day high
63.34
Prev Close
62.10
Open
62.10
6M return
102.62%
1Y return
85.64%
MCap(Rs. in Cr.)
63.92
Total Volume
18,115
Face Value : 10
Listed Since
PE Ratio

Is the price-earnings ratio for valuing a company that measures its current share price relative to its earnings per share.

P/E RATIO
0
EPS

The earnings per share ratio is a portion of company's net profit allocated for each outstanding share. It is calculated by deducting preferred stock divided from the net income of the company divided by the number of outstanding shares.

EPS
0
PRICE/BOOK

Price-to-book ratio is used to compared the company's current market price with its book value.

PRICE/BOOK
Deliverable

These are the acutal number of shares that are traded on delivery based, meaning transfered from one person to another during the day's trade.

DELIVERABLES
0
DIV YIELD.(%)

Dividend Yield measures the quantum of cash dividends paid to shareholders in a financial year relative to the market value of the per share.

DIV YIELD.(%)
0

Company Details

Check out the key parameters of the company to understand the financial health and stock performance

Key Level

Resistance 1
-
Resistance 2
-
Support 1
-
Support 2
-

Moving Average

20 Days
-
50 Days
-
100 Days
-
200 Days
-
Growth in 3 years

Sales


Sales Industry Avg


PAT


PAT Industry Avg


No data available
No data available


Relative to Sensex rtn in 3 year


Relative to Nifty rtn in 3 year


Relative to top 3 MF rtn in 3 year


2016 2014 2014
Sales 59.91 59.91 59.91
Gross Profit 60.14 60.14 60.14
Operating Profit 6.14 6.14 6.14
Sales 59.91 59.91 59.91
Gross Profit 60.14 60.14 60.14
Operating Profit 6.14 6.14 6.14

Peer Companies

A quick glance on how stocks from the same sector have performed along with some key parameters

Aspira Pathlab
63.34
Change: 1.24 (2.00%)
1 Year return
85.64%
Risk (Std Dev)
0.21%
PE Ratio
75.73171
MCap( in Cr.)
63.92
One Global Serv
297.95
Change: -6.05 (-1.99%)
1 Year return
297.11%
Risk (Std Dev)
0.35%
PE Ratio
18.81
MCap( in Cr.)
215.84
M E T S
192.50
Change: 7.25 (3.91%)
1 Year return
46.72%
Risk (Std Dev)
0.22%
PE Ratio
17.13691
MCap( in Cr.)
102.08
Choksi Laborator
132.30
Change: -2.65 (-1.96%)
1 Year return
166.41%
Risk (Std Dev)
0.30%
PE Ratio
73.34
MCap( in Cr.)
94.00
Sharma E I Hosp.
94.25
Change: -4.95 (-4.99%)
1 Year return
299.03%
Risk (Std Dev)
0.40%
PE Ratio
35.43
MCap( in Cr.)
32.54
View More

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

 

If I had made
investment of  
in
Months Ago
My investment would be worth 0 with a of 0%

News

Stay tuned to the latest developments and happenings in the company.

Aspira Pathlab & Diagnostics reports standalone net profit of Rs 0.38 crore in the December 2024 quarter

Net profit of Aspira Pathlab & Diagnostics reported to Rs 0.38 crore in the quarter ended December 2024 as against net loss of Rs 0.74 crore during th....

08 Feb 2025 07:53

Aspira Pathlab & Diagnostics to table results

Aspira Pathlab & Diagnostics will hold a meeting of the Board of Directors of the Company on 7 February 2025.Powered by Capital Market - ....

31 Jan 2025 15:44

Aspira Pathlab & Diagnostics reports standalone net profit of Rs 0.99 crore in the September 2024 quarter

Net profit of Aspira Pathlab & Diagnostics reported to Rs 0.99 crore in the quarter ended September 2024 as against net loss of Rs 0.71 crore during t....

13 Nov 2024 07:41

Aspira Pathlab & Diagnostics schedules board meeting

Aspira Pathlab & Diagnostics will hold a meeting of the Board of Directors of the Company on 12 November 2024Powered by Capital Market - ....

30 Oct 2024 16:55

Aspira Pathlab & Diagnostics AGM scheduled

Aspira Pathlab & Diagnostics announced that the Annual General Meeting (AGM) of the company will be held on 27 September 2024.Powered by ....

28 Aug 2024 12:02

Aspira Pathlab & Diagnostics reports standalone net loss of Rs 0.02 crore in the June 2024 quarter

Net Loss of Aspira Pathlab & Diagnostics reported to Rs 0.02 crore in the quarter ended June 2024 as against net loss of Rs 0.72 crore during the prev....

14 Aug 2024 07:55

View More
Subscribe for our
newsletter
GDPR CONSENT This site uses cookies. However, you can change your settings at any time. Privacy policy Settings
Open Account Now